CanadaBis CapitalTSXV:CANB Market Cap is C$2.12 Mil as of Jun. 30, 2026. The stock has 6 warning signs investors should review. Among 1,020 Drug Manufacturers companies, CanadaBis Capital ranks worse than 95.69% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). CanadaBis Capital's share price for the quarter that ended in Oct. 2025 was C$0.04. CanadaBis Capital's Shares Outstanding (EOP) for the quarter that ended in Oct. 2025 was 138.26 Mil. Therefore, CanadaBis Capital's market cap for the quarter that ended in Oct. 2025 was C$5.53 Mil.
CanadaBis Capital's quarterly market cap
declined
from Apr. 2025 (C$6.91 Mil) to Jul. 2025 (C$6.22 Mil) and
declined
from Jul. 2025 (C$6.22 Mil) to Oct. 2025 (C$5.53 Mil).
CanadaBis Capital's annual market cap
declined
from Jul. 2023 (C$40.08 Mil) to Jul. 2024 (C$7.60 Mil) and
declined
from Jul. 2024 (C$7.60 Mil) to Jul. 2025 (C$6.22 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. CanadaBis Capital's Enterprise Value for Today is C$8.79 Mil.
CanadaBis Capital (TSXV:CANB) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
CanadaBis Capital Market Cap Related Terms
CanadaBis Capital Market Cap Historical Data
* Premium members only.
The historical data trend for CanadaBis Capital's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:CANB vs NPHC, BSPK, CPMD: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CanadaBis Capital Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's Market Cap distribution charts can be found below:
* The bar in red indicates where CanadaBis Capital's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
CanadaBis Capital's Market Cap for the fiscal year that ended in Jul. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CanadaBis Capital (TSXV:CANB) has a Market Cap of C$2.12 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CanadaBis Capital and its competitors. According to the industry distribution chart, CanadaBis Capital ranks #976 out of 1020 companies in the Drug Manufacturers industry, placing it in the top 95.7%.
Is CanadaBis Capital's Market Cap too high?
CanadaBis Capital's current Market Cap is C$2.12 Mil. Based on the distribution chart, CanadaBis Capital ranks #976 out of 1020 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does CanadaBis Capital's Market Cap compare to NPHC and BSPK?
According to the Drug Manufacturers industry distribution chart, CanadaBis Capital ranks #976 out of 1020 companies for Market Cap. This places CanadaBis Capital in the lower half of its industry. The industry median Market Cap is 213.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.67, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CanadaBis Capital and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CanadaBis Capital's current Market Cap is C$2.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanadaBis Capital stock overvalued right now?
CanadaBis Capital (TSXV:CANB) has a current Market Cap of C$2.12 Mil. The stock's GF Value™ is C$0.07, compared to a current price of C$0.02 — trading 78.6% below its estimated fair value. The current Market Cap is C$2.12 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For CanadaBis Capital (TSXV:CANB), the current Market Cap is C$2.12 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:CANB has been successfully added to your 